-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$106.93126.55% Upside
Recent Analyst Forecasts and Stock Ratings
Ultragenyx Pharmaceutical Inc. Frequently Asked Questions
-
What analysts cover Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. has been rated by research analysts at H.C. Wainwright, Leerink Partners, Goldman Sachs, Stifel Nicolaus, Raymond James, Robert W. Baird in the past 90 days.